Corvus Pharmaceuticals, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Corvus Pharmaceuticals has issued its definitive proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.
NASDAQ
Corvus Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 12, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
Corvus Pharmaceuticals will hold its annual meeting of stockholders virtually on June 12, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.
NASDAQ
Corvus Pharmaceuticals announces its 2024 Annual Meeting of Stockholders to be held virtually on June 13, 2024, to vote on director election, auditor ratification, and executive compensation.
NASDAQ
Corvus Pharmaceuticals will hold its annual stockholders meeting virtually on June 13, 2024, to vote on director election, auditor ratification, and executive compensation.